Bayer Middle East FZ-LLC
Bayer has been present in the Middle East since the late 1880s. Operations in the Middle East are headquartered in Dubai, United Arab Emirates. Moreover, Bayer has legal entities and representations in Cyprus, Egypt, Jordan, and Saudi Arabia. In other countries in this region, Bayer’s products are marketed by distributors and third-party agencies. Bayer has more than 800 employees in this region. During 2015, the Life Science activities in the region showed double-digit growth (Fx & portfolio adj) compared to the previous year, resulting in EUR 430 million in sales.
See below for the latest Bayer Middle East FZ-LLC News, Analysis, Profit Results, Share Price Information and Commentary
Bayer Middle East's "Albak Amanah" initiative honoured for tackling Egypt's cardiovascular health crisis
Bayer Middle East's "Albak Amanah" initiative honoured for tackling Egypt's cardiovascular health crisis
The initiative, launched in partnership with the Egyptian Ministry of Health & Population, aims to save lives by raising awareness about cardiovascular diseases (CVDs) and providing essential healthcare services to those most vulnerable.
Commentary
Why Asia’s private wealth industry requires a new era of governance
The eastward shift in the biotech world: Why India and China could lead the next wave
Why is APAC travel retail betting on experience over discounts?
Reinsurance beyond borders: How Hong Kong can strengthen Asia’s risk-sharing architecture
APAC has mastered domestic payments. The next challenge is connecting them.
Why fragmented communications are becoming a hidden governance risk for Asia Pacific banks
Why Starbucks wins where Walmart lost: The invisible layer of East Asian retail
From automation to agency: Asia’s wealth leaders can reinvent, not just streamline
Why efficiency and innovation conflict and what organisations can learn from Asia
Why delayed intervention is becoming Asia's biggest reliability risk